MedTrace Logo

Guided Imagery for Nausea and Well-Being in Pregnant Women

NCT07544095 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2026-04-22

No results posted yet for this study

Summary

This study aims to evaluate the effect of a guided imagery-based psychoeducational intervention on nausea and vomiting severity and psychological well-being in pregnant women. The intervention includes structured psychoeducation and guided imagery sessions designed to promote relaxation, enhance symptom management, and improve overall well-being. Pregnant women in the first trimester experiencing nausea and vomiting were randomly assigned to either the intervention group or the control group. The intervention group received a four-session guided imagery-based psychoeducation program supported by home-based audio practice, while the control group received routine antenatal care. Outcomes were assessed before and after the intervention using standardized measurement tools.

Conditions

  • Nausea and Vomiting in Pregnancy

Interventions

BEHAVIORAL

Guided Imagery-Based Psychoeducation

A structured psychoeducational program based on guided imagery techniques, consisting of four face-to-face sessions aimed at reducing nausea and vomiting symptoms and improving psychological well-being. Participants were instructed to practice guided imagery daily at home using standardized audio recordings.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Tuba Enise Benli · Giresun University

  • Yeşim Aksoy Derya · Inonu University

  • Kader Atabey · Inonu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-26
Primary Completion
2024-12-15
Completion
2024-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07544095 on ClinicalTrials.gov